Immunotherapy of metastatic breast cancer: phase I trail of reduced-intensity allogeneic hematopoietic stem cell transplantation with Th2/Tc2 T-cell exchange

Clin Breast Cancer. 2006 Apr;7(1):87-9. doi: 10.3816/cbc.2006.n.019.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Research Support, N.I.H., Intramural

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / therapy*
  • Female
  • Graft Rejection
  • Graft Survival
  • Graft vs Tumor Effect / immunology*
  • Hematopoietic Stem Cell Transplantation / methods*
  • Humans
  • Immunotherapy, Adoptive / methods
  • Infant, Newborn
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Prognosis
  • Prospective Studies
  • Risk Assessment
  • T-Lymphocytes, Cytotoxic / immunology
  • Th2 Cells / immunology
  • Transplantation Conditioning / methods*
  • Transplantation Immunology
  • Transplantation, Homologous